173 filings
Page 3 of 9
8-K
pxrfuipswgz93t 7rdag
23 Jun 22
Timber Pharmaceuticals Announces First Patients Enrolled in Phase 3 ASCEND Clinical Trial Evaluating TMB-001 in Congenital Ichthyosis
8:15am
8-K
dw56n9r vv5bb6t
10 Jun 22
Regulation FD Disclosure
4:05pm
8-K
5iacnbfvm6
7 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
ij0znw83i 7zc7ncqq
31 May 22
Timber Pharmaceuticals Receives FDA Breakthrough Therapy Designation for TMB-001 for the Treatment of Congenital Ichthyosis
8:18am
8-K
qd0r e93yojn7
12 May 22
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2022 Financial Results
4:32pm
8-K
wi9vhnhi0w434f7t
28 Apr 22
Timber Pharmaceuticals Announces Fast Track Designation Granted by FDA for TMB-001 in Severe Subtypes of Congenital Ichthyosis
8:20am
8-K
lhffct
25 Apr 22
Other Events
5:16pm
8-K
i5oauiixtvx4cedu
11 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
15rf98m
31 Mar 22
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2021 Financial Results
6:20pm
8-K
iuzyfx5rfutwlupb63a
25 Mar 22
Timber Pharmaceuticals Announces Late-Breaking Presentation at the American Academy of Dermatology 2022 Annual Meeting
4:05pm
8-K
q9nk5g
3 Feb 22
Timber Pharmaceuticals Announces Positive End-of-Phase 2 Meeting with FDA for TMB-001 in Moderate to Severe Congenital Ichthyosis
8:15am
8-K
sokvh0pc9bdqouf
18 Jan 22
Departure of Directors or Certain Officers
4:04pm
8-K
iqekbjt7n3te1
8 Dec 21
Regulation FD Disclosure
9:04am
8-K
2z95bbczbje ukcv9p
22 Nov 21
Regulation FD Disclosure
9:15am
8-K
9zd233b szjrd6vgu66x
15 Nov 21
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2021 Financial Results
12:00am
8-K
0r0e0d
4 Nov 21
Timber Pharmaceuticals Announces Proposed Public Offering
4:23pm
8-K
cysnz
7 Oct 21
Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis
8:59am
8-K
6vl7j
29 Sep 21
Departure of Directors or Certain Officers
8:00am
8-K
mgj0yf
16 Sep 21
Departure of Directors or Certain Officers
4:11pm
8-K
4132q3 als7kmk
13 Sep 21
Regulation FD Disclosure
12:00am